| Literature DB >> 33816224 |
Yan Zhang1, Weiping Liu2, Xinyue Zhang3, Bing Wu1.
Abstract
Background: Extranodal NK/T cell lymphoma is a rare non-Hodgkin lymphoma mainly involving the upper aerodigestive tract, even rarer is primary extranasal disease involving the intestine. We present a case of primary intestinal NK/T cell lymphoma with diagnostic challenge, which eventually developed into multiple intestinal perforations. Case Presentation: A 35-year-old man presented with diarrhea and recurrent fever. Abdominal CT revealed multi-segmental intestinal wall thickening. Colonoscopy showed multiple irregular ulcers in colon. During the hospitalization, the patient developed intestinal perforation and an emergency surgery was performed. The resected specimen showed multiple perforations of the colon. The surgical samples underwent pathological analysis, and a diagnosis of extranodal NK/T cell lymphoma nasal type was confirmed. After recovering from surgery, the patient started receiving chemotherapy and PD-1 monoclonal antibody. Fortunately, he was discharged after significant improvement in his general condition. Eleven months follow-up was uneventful.Entities:
Keywords: Intestinal neoplasm; Nk/t cell lymphoma; extranodal; non-Hodgkin lymphoma; perforation
Year: 2021 PMID: 33816224 PMCID: PMC8010170 DOI: 10.3389/fonc.2021.577939
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Colonoscopy. There are multiple irregular ulcers in the colon. (A) Ascending colon. (B) Sigmoid colon.
Figure 2Whole abdominal CT. CT scan showing wall thickening of the colon (arrows). CT scan showing a large amount of free gas in abdominal cavity (arrow). (A) Coronal view. (B) Sagittal view.
Figure 3F-18 fluorodeoxyglucose positron emission tomography with computed tomography (18F-FDG PET/CT) showing significant increased FDG uptake in the intestinal wall of the whole colon. (A) Body maximum intensity projection (MIP) image. (B) abdominal PET/CT.
Figure 4Histological and immunohistochemical pictures of the lymphoma. (A) The tumor cells infiltrated the whole wall of the colon. (B) Diffusely infiltrating of medium-sized tumor cells with irregular nuclei (arrows). Immunohistochemical stains showing the tumor cells are positive for (C) CD3, (E) CD43, (G) GB, and (H) EBER, and negative for (D) CD5, (F) CD56. (I) The Ki-67 labeling index was around 60%.
Summary of the published cases of primary intestinal NK/T cell lymphoma.
| Duan et al. ( | 12 | M | Abdominal pain, fever | Colon | Medium-sized atypical lymphoid cells with large areas of necrosis | CD2+, CD3+, CD4+, CD5+, CD8+, CD43+,CD56+, TIA-1+, GB+, Ki-67: 60% | Positive | Surgery | Within 1 month |
| Li et al. ( | 40 | F | Loose stools, fever | Colon | Focal heterotypic lymphocyte infiltration?heterotypic lymphocyte clusters | CD2+, CD3+, CD5+, CD20+, CD34+, CD61+, CD79α TIA-1+, Ki-67: 40% | Positive | Methylprednisolone combined with Podexan and a salford enema | a few months |
| Lookzadeh et al. ( | 56 | M | Fever, productive cough, dyspnea, Vomiting, chill | Terminal ileum | Infiltration of pleomorphic neoplastic lymphoid cells | CD3+, CD8+, CD30+, CD56+, LCA+, Ki-67: 70% | N/A | Surgery | N/A |
| Yang et al. ( | 15–72 | M: 9; F: 4 | Abdominal pain, gastrointestinal bleeding, diarrhea, fever | Small intestine: 4; large intestine: 9 | The tumor cells were predominantly medium to small in size | CD3ε+, CD5+, CD56+, CD43+, TIA-1+, GB+, The Ki-67 index ranged from 30 to 70% | Positive | Surgery, chemotherapy, Surgery + chemotherapy | 6 months |
| Wang et al. ( | 24–54 | M: 6; F: 6 | Abdominal pain, haematochezia, diarrhea, weight loss, fever | ileal: 1; ileocecum: 7; colon: 9; rectum: 5 | Chronic mucosal/submucosal inflammatory infiltrates with clusters of medium- or small-sized lymphoid cells | CD3ε+, CD56+, TIA-1+, GB+, The Ki-67 index ranged from 5 to 80% | Positive | Surgery, chemotherapy, Surgery + chemotherapy | 6.3 months |
| Tang et al. ( | 15–85 | M: 14; F: 3 | Abdominal pain, haematochezia, diarrhea | Small intestine: 5; ileocecum: 5; colon: 10 | The tumor cells were small (23.5%), medium to small (41.2%) and medium (23.5%), medium to large (11.8%) in size | CD8+, CD30+, CD56+, TIA-1+, GB+ | Positive | Surgery, chemotherapy, Surgery + chemotherapy | 4.3 months |
| Yu et al. ( | 14–75 | M: 37; F: 18 | Abdominal pain, lower GI bleeding or fecal occult blood, fever | Small intestine: 28; ileocecum: 11; colon: 13; different intestinal segments: 3 | The atypical lymphoid cells infiltrated, the tumor cells were displayed a mixed population of small, medium to large (43.6%), small to medium (32.7%), medium (21.8%), small (1.8%) in size | CD2+, CD4+, CD5+, CD7+, CD8+, CD30+, CD56+, TIA-1+, GB+, The Ki-67 index ranged from 50 to 90% | Positive | Surgery, chemotherapy, Surgery + chemotherapy | 12.7 months |
| Chen et al. ( | 29 | M | Abdominal pain, diarrhea, haematochezia, fever | Small intestine | The tumor cells were large in size | CD56+, Ki-67: 10% | Positive | Surgery + chemotherapy | 20 d |
| Fang et al. ( | 24–68 | M: 7; F: 3 | Abdominal pain, diarrhea, haematochezia, fever | Small intestine | The tumor cells were small (20%), medium (20%), large (50%) in size, or mixed medium and large cells (10%) | CD2+, CD3+, CD30+, CD56+, TIA-1+, GB+, The Ki-67 index ranged from 40 to 90% | Positive | Surgery, chemotherapy, Surgery + chemotherapy | 9.5 months |
| Aniwan et al. ( | 29 | M | Abdominal pain, bloody diarrhea, fever, weight loss | Colon | Small lymphoid cells | CD3+, CD56+ | Positive | Surgery | N/A |
| Zheng et al. ( | 37 | M | Abdominal pain, bloody diarrhea, fever | Colon | Diffuse proliferation of small and medium sized atypical lymphoid cells | CD3ε+, CD56+, GB+ | Positive | Surgery + chemotherapy | 3 months |
| Mahuad et al. ( | 52 | M | Fever | Colon | The tumor cells were medium to large in size | CD2+, CD56+, CD20+, GB+, Ki-67: 40% | Positive | Surgery + chemotherapy | 2 months |
| Zheng et al. ( | 15–65 | M: 16; F: 9 | Abdominal pain, fever, weight loss, diarrhea, hematochezia | Small intestine: 8; ileocecum:8, large intestine: 16 | The tumor cells were predominantly medium or large in size | CD3+, CD56+, GB+, The Ki-67 index ranged from 50 to 80% | Positive | Surgery, chemotherapy, surgery + chemotherapy | 7 months |
| Panarelli et al. ( | 37 | F | GI bleeding | Small intestine | The tumor cells were medium to large in size | CD2+, CD3+, CD7+, CD56+ | Positive | Surgery | N/A |
| Wakabayashi et al. ( | 47 | M | Abdominal pain, bloody stool, fever | Small intestine | Extensive diffuse infiltration by atypical lymphocytes in the lamina propria prosae | CD3+, GB+ | Positive | Surgery + BMT | 14 months |
| Kakimoto et al. ( | 73 | M | N/A | Rectum | The tumor cells were large in size | CD3+, CD56+, GB+ | Positive | Surgery | N/A |
| Moubayed et al. ( | 72/59 | M | Abdominal pain, weight loss, diarrhea | Terminal ileum | The tumor cells were large in size | CD2+, CD3+, CD7+, CD8+, CD56+, TIA-1+ | Negative | Surgery/surgery + chemotherapy | N/A |
F, female; M, male; ISH, in situ hybridization; EBER, EBV-encoded small RNA; OS, overall survival; TIA-1, T-cell restricted intracellular antigen 1; GB, granzyme B; N/A, not available; GI, gastrointestinal; BMT, bone marrow transplant.